[841]
Noonan syndrome associated with neuroblastoma: a case report
[15,6 KB]
From [www.springerlink.com] Last viewed: 28.08.2004
Vo l u m e 3 41
Nu m b e r 16
·
1165
The New England
Journal
of
Medicine
© C o py r ig ht , 19 9 9 , by t he Ma s s ac h u s e t t s Me d ic a l S o c ie t y
V O L U M E 3 4 1
O
C T O B E R
1 4 , 1 9 9 9
N U M B E R 1 6
TREATMENT OF HIGH-RISK NEUROBLASTOMA WITH INTENSIVE
CHEMOTHERAPY, RADIOTHERAPY, AUTOLOGOUS BONE MARROW
TRANSPLANTATION, AND 13-
CIS
-RETINOIC ACID
K
ATHERINE
K. M
ATTHAY
, M.D., J
UDITH
G. V
ILLABLANCA
, M.D., R
OBERT
C. S
EEGER
, M.D., D
ANIEL
O. S
TRAM
, P
H
.D.,
R
ICHARD
E. H
ARRIS
, M.D., N
ORMA
K. R
AMSAY
, M.D., P
ATRICK
S
...
[842]
EXTENSIVE GENETIC HETEROGENEITY IN THE NEUROBLASTOMA CELL LINE NB ...
[29,0 KB]
From [dx.doi.org] Last viewed: 28.08.2004
N Engl J Med, Vol. 346, No. 14
·
April 4, 2002
·
www.nejm.org
·
1047
N E U R O B L ASTO M A S C R E E N I N G
NEUROBLASTOMA SCREENING AT ONE YEAR OF AGE
F
REIMUT
H. S
CHILLING
, M.D., C
LAUDIA
S
PIX
, P
H
.D., F
RANK
B
ERTHOLD
, M.D., R
UDOLF
E
RTTMANN
, M.D.,
N
ATALJA
F
EHSE
, M.D., B
ARBARA
H
ERO
, M.D., G
ISELA
K
LEIN
, P
H
.D., J
OHANNES
S
ANDER
, M.D., K
ERSTIN
S
CHWARZ
, M.D.,
J
OERN
T
REUNER
, M.D., U
LRICH
Z
ORN
, P
H
.D.,
AND ...
[843]
Thoracic Neuroblastoma Presented With Chronic Cough: Report Of One ...
From [www.pedipulm.org.tw] Last viewed: 28.08.2004
77 ?
Thoracic Neuroblastoma Presented With Chronic
Cough: Report Of One Case
Mao-Tsair Lin, Shyh-Dar Shyur, Li-Hsin Huang, Jiunn-Yi Wu,Yi-Chun Ma, Der-Cherng Liang
Department of pediatrics, Mackay Memorial Hospital, Taipei, Taiwan
Abstract
Chronic cough may be induced by pneumonia, gastroesophageal reflux, asthma, TB or lung
neoplasms etc. Here we report a 4-year-old boy with chronic cough for nearly 2 months. Chest
roentgenogram revealed a huge mediastinal mass. Neuroblastoma was proved by the pathology of
open lung biopsy. In a patient with chronic cough, chest roentgenogram is indicated if there is no
improvement after medical treatment.
Key word: neuroblastoma , chronic cough
Introduction
Neuroblastoma is the most common solid
tumor of childhood outside central nervous
system neoplasm. It may be incidentally noted
on a chest roentgenogram ...
[844]
Arf6, His-Tagged, Human Neuroblastoma (NIE115), Recombinant, E. ...
From [www.merckbiosciences.co.uk] Last viewed: 28.08.2004
Australia
Tel (02) 9318 0322
Germany
Tel 0800 6931 000
Japan
Tel (03) 5443 0281
United Kingdom
Tel 0115 9430 840
USA, Canada, Mexico
Tel (800) 628-8470
E-mail address for technical inquiries: technical@calbiochem.com
Find our current product data sheets on the web: http://www.calbiochem.com
Revised: 14-Dec-98
Arf6, His-Tagged, Human Neuroblastoma (NIE115),
Recombinant, E. coli
Size
Cat. No.
181329
2
µ g
Description:
ADP-ribosylation factors (Arfs) are GTP-binding proteins that are
allosteric activators of NAD:arginine ADP-ribosyltransferase activity of
cholera toxin. They are known to regulate intracellular vesicular traffic
and stimulate the activity of phospholipase D. Arf6 is localized in cell
plasma membranes and membranes of secretory chromaffin granules. It
is thought to play a role in receptor-mediated ...
[845]
Arf5, His-Tagged, Human Neuroblastoma (NIE115), Recombinant, E. ...
From [www.merckbiosciences.co.uk] Last viewed: 28.08.2004
Australia
Tel (02) 9318 0322
Germany
Tel 0800 6931 000
Japan
Tel (03) 5443 0281
United Kingdom
Tel 0115 9430 840
USA, Canada, Mexico
Tel (800) 628-8470
E-mail address for technical inquiries: technical@calbiochem.com
Find our current product data sheets on the web: http://www.calbiochem.com
Revised: 14-Dec-98
Arf5, His-Tagged, Human Neuroblastoma (NIE115),
Recombinant, E. coli
Size
Cat. No.
181327
2
µ g
Description:
ADP-ribosylation factors (Arfs) are GTP-binding proteins that are
allosteric activators of NAD:arginine ADP-ribosyltransferase activity of
cholera toxin. They are known to regulate intracellular vesicular traffic
and stimulate the activity of phospholipase D. Arf5 is predominantly
cytosolic, but can be recruited to the Golgi membranes upon binding to a
non-hydrolyzable analog of GTP. Provided as ...
[846]
Neuroblastoma the basics
[216,4 KB]
From [www.chw.edu.au] Last viewed: 30.07.2004
Neuroblastoma – the basics
Disclaimer: This fact sheet is for education purposes only. Please consult with your doctor or other
health professional to make sure this information is right for your child.
This information sheet will tell you in simple terms:
What is a neuroblastoma ?
Why did the neuroblastoma happen?
What problems does neuroblastoma cause?
How did we find the neuroblastoma ?
How do we treat neuroblastoma ?
What is a neuroblastoma ?
A neuroblastoma is a type of cancer - a lump of cells (tumour) which should not be there.
Neuroblastoma is a cancer that only children get. It starts from primitive (very simple) nerve cells found
in areas where nerves join together. The most common areas where these are found are in the
abdomen (especially the adrenal gland), chest and neck.
Why did the neuroblastoma happen?
In most cases, we do not know ...
[847]
Infant Neuroblastoma the basics
[216,2 KB]
From [www.chw.edu.au] Last viewed: 30.07.2004
Infant Neuroblastoma – the basics
Disclaimer: This fact sheet is for education purposes only. Please consult with your doctor or other
health professional to make sure this information is right for your child.
This information sheet will tell you in simple terms:
What is a neuroblastoma ?
Why did the neuroblastoma happen?
How did we find the neuroblastoma ?
How do we treat neuroblastoma ?
What is a neuroblastoma ?
A neuroblastoma is a type of cancer - a lump of cells (tumour) which should not be there.
Neuroblastoma is a cancer that only children get. It starts from primitive (very simple) nerve cells found
in areas where nerves join together. The most common areas where these are found are in the
abdomen (especially the adrenal gland), chest and neck.
Why did the neuroblastoma happen?
Neuroblastoma is the most common type of cancer in babies. In most ...
[848]
Molecular profiling of high-risk neuroblastoma by cDNA array
[93,7 KB]
From [147.52.72.117] Last viewed: 30.07.2004
Abstract.
The aim of this study was to investigate gene
expression changes in disseminated neuroblastoma by cDNA
array technique. Three stage IV neuroblastomas and one
neuroblastoma cell line (SK-N-FI) were analyzed. Expression
profiles were confirmed by semiquantitative RT-PCR and in
some instances by Northern blotting. Comparison of expression
profiles identified several genes which were highly expressed
as well as some which were down-regulated in tumor samples
relatively to SK-N-FI cells. The tumors studied lacked N-
myc overexpression, while showing up-regulation of basic
trans-cription factors, growth factors and receptors such as
NSEP, c-myc binding protein MM1, thymosin ß10 (TMSB10),
TNF-R superfamily member 10A (TNFRSF10A) and FZ9.
These results suggest that cDNA array technology is a
powerful tool to identify a set of genes involved in
neuroblastoma genesis and progression. ...
[849]
PHENOTYPIC PROPERTIES OF CHOLINERGIC SN56 MOUSE NEUROBLASTOMA ...
[21,0 KB]
From [www.kenes.com] Last viewed: 30.07.2004
neuroblastoma
PHENOTYPIC PROPERTIES OF CHOLINERGIC SN56 MOUSE NEUROBLASTOMA CELLS TRANSFECTED WITH CHOLINE ACETYLTRANSFERASE GENE
H.Bielarczyk, M. Tomaszewicz, B. Madziar, M. Gniezdzinska, A. Szutowicz
Chair of Clinical Biochemistry, Department of Laboratory Medicine, Medical University of Gdansk, Poland
Particular susceptibility of cholinergic neurons to neurodegenerative insults may result from the fact that they require extra amounts of choline and acetyl-CoA for acetylcholine (ACh) synthesis. Cholinergic hybrid neuroblastoma SN56 cells of septal origin display several features of septal cholinergic neurons but express relatively low choline acetyltransferase (ChAT) activity. To restore ChAT activity similar to that present in brain cholinergic neurons, native SN56 cells were transfected with plasmid PSRNEO containing rat cDNA ChAT and geneticin resistance gene. Stable transfection yielded cells (SN56ChAT) with ChAT ...
[850]
Genistein modulates neuroblastoma cell proliferation and ...
[315,2 KB]
From [carcin.oupjournals.org] Last viewed: 30.07.2004
D
ATA
S
HEET
Rev 030502D
Neuroblastoma Marker Ab-1 (Clone NB84a)
Mouse Monoclonal Antibody
Cat. #MS-492-S0, -S1, or -S (0.1ml, 0.5ml, or 1.0ml Supernatant)
Cat. #MS-492-R7 (7.0ml) (Ready-to-Use for Immunohistochemical Staining)
Cat. #MS-492-PCS (5 Slides) (Positive Control for Histology)
#&&( ÃXrvtu?rÃ9? ÃA?r?Ã86ÃÃ(#$"(ÃVT6Ã
Ury)Ã ' Ã'!' %!'ÃÃAh?)Ã $ Ã(( !'!%Ã
@?hvy)Ãyhi?v?v?5yhi?v?v? pÃÃXri?v?r)Ã yhi?v?v? p
Comments:
Ab-1 recongizes a protein of 57kDa
which is found in a wide range of normal tissues,
including most epithelia and endothelial cells. Ab-1
is useful in identification of pediatric, small round
blue cell tumors. Approximately 90% of
neuroblastomas are stained by this antibody whereas
all other tumor types such as leukemia,
rhabdomyosarcomas, and Wilm’s tumors are ...
[851]
Arsenic Trioxide-Induced Death of Neuroblastoma Cells Involves ...
From [clincancerres.aacrjournals.org] Last viewed: 30.07.2004
Last Revised: 3/5/2003
UM Cancer Center
Patient Education Document #0007
Mar03 Ed.
Online version: http://www.cancer.med.umich.edu/learn/percpathways.htm
University of Michigan Comprehensive Cancer Center
Patient Education Resource Center (PERC)
INFORMATION GUIDE
Childhood Cancer: Neuroblastoma
The purpose of this information guide is to help parents of children newly diagnosed with Neuroblastoma find
sources of information and support. This list is not meant to be comprehensive, but rather to provide starting
points for information seeking. The materials can be found at the Patient Education Resource Center at the
University of Michigan Comprehensive Cancer Center in room B1-361.
Article
Available in the Patient Education Resource Center level B1 room 361
Reynolds, Patrick C. Treating High-Risk Neuroblastoma at the ...
[852]
Congenital mediastinal dumbbell neuroblastoma with spontaneous ...
[16,5 KB]
From [www.springerlink.com] Last viewed: 30.07.2004
1
DIAGNOSTIC IMAGING IN NEUROBLASTOMA
Hans Ringertz, M.D., Ph.D.
INTRODUCTION
Neuroblastoma is a biologically very special neoplasm that is unique to child-
hood. As can be seen from Table 1 it is the fourth most common paediatric
malignancy in the Nordic countries and constitutes around 6% of all
malignancies in children.
Neoplasm in patients below 16 years of age in the
Nordic countries during the years 1985 and 2001 in
order of frequency
No. of
new
cases
%
1 Leukaemia
3249
34
2 Central nervous system and intracranial and intraspinal
neoplasm
2596
27
3 Lymphomas and other reticuloendothelial neoplasm
1116
11
4 Sympathetic nervous system tumours
595
6
5 Renal tumours
556
6
6 Soft tissue sarcomas
540
5
7 Malignant bone tumours
297
3
8 Germ-cell, trophoblastic ...
[853]
Farnesyltransferase inhibitor FTI-277 prevents autocrine growth ...
[17,0 KB]
From [www.springerlink.com] Last viewed: 30.07.2004
1
DIAGNOSTIC IMAGING IN NEUROBLASTOMA
Hans Ringertz, M.D., Ph.D.
INTRODUCTION
Neuroblastoma is a biologically very special neoplasm that is unique to child-
hood. As can be seen from Table 1 it is the fourth most common paediatric
malignancy in the Nordic countries and constitutes around 6% of all
malignancies in children.
Neoplasm in patients below 16 years of age in the
Nordic countries during the years 1985 and 2001 in
order of frequency
No. of
new
cases
%
1 Leukaemia
3249
34
2 Central nervous system and intracranial and intraspinal
neoplasm
2596
27
3 Lymphomas and other reticuloendothelial neoplasm
1116
11
4 Sympathetic nervous system tumours
595
6
5 Renal tumours
556
6
6 Soft tissue sarcomas
540
5
7 Malignant bone tumours
297
3
8 Germ-cell, trophoblastic ...
[854]
Experimental study of thymidine kinase gene therapy of ...
[19,5 KB]
From [www.springerlink.com] Last viewed: 30.07.2004
1
DIAGNOSTIC IMAGING IN NEUROBLASTOMA
Hans Ringertz, M.D., Ph.D.
INTRODUCTION
Neuroblastoma is a biologically very special neoplasm that is unique to child-
hood. As can be seen from Table 1 it is the fourth most common paediatric
malignancy in the Nordic countries and constitutes around 6% of all
malignancies in children.
Neoplasm in patients below 16 years of age in the
Nordic countries during the years 1985 and 2001 in
order of frequency
No. of
new
cases
%
1 Leukaemia
3249
34
2 Central nervous system and intracranial and intraspinal
neoplasm
2596
27
3 Lymphomas and other reticuloendothelial neoplasm
1116
11
4 Sympathetic nervous system tumours
595
6
5 Renal tumours
556
6
6 Soft tissue sarcomas
540
5
7 Malignant bone tumours
297
3
8 Germ-cell, trophoblastic ...
[855]
I78 NEUROBLASTOMA SCREENING STUDY ENABLES ADEQUATE DECISION ON ...
From [www.kukm.de] Last viewed: 30.07.2004
I78
NEUROBLASTOMA SCREENING STUDY ENABLES ADEQUATE DECISION ON FURTHER
DEVELOPMENT OF LEGISLATIVE EARLY DETECTION PROGRAMME
B. Metzinger, IKK-Bundesverband (Bergisch Gladbach)
Studies about the effectiveness of screening are rare and far between in Germany. Realization of such studies
usually is declined because of alleged ethical reasons. Consequently screening examinations are executed
without previous effectiveness checks and quality management. Especially examinations in healthy individuals
require evidence for their benefit. Necessarily the risk (including the risk of further examination) vs. benefit
(better prognosis for early detected diseases) have to be weighed.
The pilot project " Neuroblastoma screening" is a positive example for the intention of all persons concerned
realizing a study to proove the benefit of a screening test. The result of the project answers the question whether
screening ...
[856]
Nursing Experiences of Caring a Child with Neuroblastoma
[29,7 KB]
From [www.tzuchi.com.tw] Last viewed: 25.07.2004
!"#$ P
O
! VP
S
NMU
ABSTRACT
A child with neuroblastoma was hospitalized due to fever on November 6, 2003. During the hospitalization (11/06/
2003-12/06/2003), the peripheral stem cells were collected from this child. The caring duration of the author was from
November 20, 2003 through November 26, 2003. This article describes the medical and nursing interventions imple-
mented for solving this child's health problems. As Gordon's 11 Functional Health Assessment served as an assessment
guide, four health problems, such as risk for infection, altered oral mucous membrane, hyperthermia, and pain, were
identified. In order to solve four health problems mentioned above, nursing goals were first identified and nursing inter-
ventions were then implemented. After evaluating the nursing care planed for this child, four health problems were either
improved or solved. This care experience may provide health ...
[857]
Negative Regulation of Neuroblastoma Cell Growth by Carbohydrate ...
[314,4 KB]
From [www.vetmed.uni-muenchen.de] Last viewed: 25.07.2004
Negative Regulation of Neuroblastoma Cell Growth by
Carbohydrate-dependent Surface Binding of Galectin-1 and
Functional Divergence from Galectin-3*
Received for publication, June 5, 2001, and in revised form, July 12, 2001
Published, JBC Papers in Press, July 12, 2001, DOI 10.1074/jbc.M105135200
Ju
¨ rgen Kopitz‡, Carolina von Reitzenstein‡, Sabine Andre´§, Herbert Kaltner§, Johannes Uhl‡,
Volker Ehemann
¶
, Michael Cantz‡ , and Hans-Joachim Gabius§
From the ‡ Institut fu
¨ r Pathochemie und Neurochemie and the
¶
Pathologisches Institut, Klinikum der Ruprecht-Karls-
Universita¨t, Im Neuenheimer Feld 220, D-69120 Heidelberg, Germany and the § Institut fu
¨ r Physiologische Chemie,
Tiera¨rztliche Fakulta¨t, Ludwig-Maximilians-Universita¨t, Veterina¨rstr. 13, D-80539 Mu
¨ nchen, Germany
The cell density-dependent growth inhibition ...
[858]
Microsoft PowerPoint - Neuroblastoma mimicing cervical & ...
[852,5 KB]
From [peds.wustl.edu] Last viewed: 25.07.2004
2 ½ year old female
• Presents to OSH in respiratory distress.
– 5 days of sore throat, dysphagia, and poor PO intake
– 1 day PTA Fever 103
– Increasing cervical adenopathy
• At OSH XR neck ?compromised airway/pre-
vertebral swelling.
• CXR +RUL collapse
• Pt intubated with difficulty, sedated and paralyzed
• Dexamethasone single dose.
• Started on broad spectrum antibiotics.
Page 2
Outside Hospital Course
• Initially hypotensive and poorly perfused,
requiring IVF and dopamine
• ECHO normal. Creatine normal.
• Local CT/MRI with numerous neck/chest
masses/nodes
• Continued to have daily fevers despite
negative blood & urine cultures.
• Transferred to SLCH Pediatric ICU on
Hosp d#5
Page 3
Page 4
• PMH :
–
–
– ...
[859]
NEUROBLASTOMA - All Sections
[68,3 KB]
From [documents.cancer.org] Last viewed: 25.07.2004
NEUROBLASTOMA - All Sections
NEUROBLASTOMA
What Is Cancer?
Cancer is a group of many related diseases. All forms of cancer cause cells in the body to change
and grow in an abnormal way.
Normal body cells divide and grow in an orderly fashion. But cancer cells divide and grow out of
control. This out-of-control growth damages normal body tissues and disrupts the ability of organs
to function as they should.
During the early years of a person's life, normal cells divide more rapidly until adult size is
reached. After that, normal cells of most tissues divide only to replace worn-out tissue and to
repair injuries.
Cancer cells, however, continue to grow. Often the cells form tumors (lumps) that compress,
invade, and destroy normal tissue. Unless the cancer is treated, the tumors can grow and spread. If
cells break away from such a tumor, they can travel through the bloodstream or ...
[860]
Misdiagnosis of olfactory neuroblastoma
[131,1 KB]
From [www.aans.org] Last viewed: 25.07.2004
Olfactory neuroblastomas are relatively uncommon tu-
mors that originate from the olfactory epithelium in the
upper nasal cavity in the region of the cribriform plate.
Although some controversy persists, their primary modal-
ity of therapy is resection, usually performed by an an-
terior craniofacial approach and with the provision of ad-
juvant radiation therapy.
29
In addition, recent experience
suggests that there may be a therapeutic role for adjuvant
chemotherapy.
4
A variety of other neoplastic lesions occur
in the same anatomical region as ONs. Tumors such as
NEC, melanoma, sinonasal lymphoma, SNUC, and pitu-
itary adenoma can all present with similar clinical, histo-
logical, and radiological features as ON. The prognosis
and therapeutic modalities for these different tumors are
variable, and physicians treating neoplasms arising from
the paranasal sinus region ...
[861]
Expression of the caspase-8 gene in neuroblastoma cells is ...
[150,6 KB]
From [www.nature.com] Last viewed: 25.07.2004
Letter to the Editor
Expression of the caspase-8 gene in neuroblastoma
cells is regulated through an essential interferon-
sensitive response element (ISRE)
Cell Death and Differentiation (2004) 11, 131–134. doi:
10.1038/
sj.cdd.4401327
Published online 7 November 2003
Dear Editor,
It is well known that caspase-8 is an ‘initiator’ caspase acting
at the top of the apoptotic cascade.
1–3
Specific ligand
engagement by death receptors of the TNF-R superfamily or
CD95/FAS induces receptor aggregation and recruitment of
the Fas-associated death domain and caspase-8 mole-
cules.
4,5
Thus, caspase-8 becomes activated and further
activates, by enzymatic cleavage, the downstream ‘effector’
caspases.
6,7
The silencing of caspase-8 gene was observed
in several tumors, where it was related to resistance to death-
inducing ligands, ...
[862]
Neuroblastoma
[176,9 KB]
From [www.vicc.org] Last viewed: 25.07.2004
Neuroblastoma
ANBL00B1
Biology
Perinatal
Low Risk
Intermediate
Relapse
High Risk
COG P9641
Primary
Surgical
Therapy
COG A3961
CTX, VP-16,
CBDCA, DOX
COG A3973
Phase III:
PBSCT
ANBL00P2
Expectant
Observation
K E Y
Pending
Suspended
Open
Revised 11/19/03
Team Leader Signature and Date
COG P9761
Phase II:
Irinotecan
*1st Priority
COG P9963
Phase II:
Rebeccamycin
Analog
*2nd Priority
ADVL 0122
Phase II:
Gleevec
*3rd Priority
ANBL-0321
Phase II:
Fenretinide
*4th Priority
[863]
Thalidomide is anti-angiogenic in a xenograft model of ...
[270,1 KB]
From [147.52.72.117] Last viewed: 25.07.2004
Abstract.
Thalidomide has previously been shown to have anti-
angiogenic properties. More recently, clinical efficacy of this
agent has been demonstrated in multiple myeloma and
prostate cancer. Neuroblastoma is the most frequent solid
tumor of the abdomen of childhood, yet children with this
disease frequently have metastases at presentation. Such
patients have a very poor prognosis with current therapies.
Thus, new approaches are needed. We have previously shown
that VEGF antagonists can inhibit neoangiogenesis and tumor
growth in experimental neuroblastoma . In this study, we
investigated the anti-angiogenic and anti-tumor properties of
thalidomide in a xenograft model of human neuroblastoma .
Tumors were induced in athymic mice using the human
neuroblastoma cell line NGP. Intraperitoneal thalidomide
(100 mg/kg/dose) or vehicle was administered beginning one
week after implantation, ...
[864]
RETINOIDS IN EXPERIMENTAL NEUROBLASTOMA THERAPY Frida Ponthan
[946,8 KB]
From [diss.kib.ki.se] Last viewed: 25.07.2004
Clinical Categories of Neuroblastoma Are
Associated with Different Patterns of Loss of
Heterozygosity on Chromosome Arm 1p
Jaume Mora,* Nai-Kong V. Cheung,*
Brian H. Kushner,* Michael P. LaQuaglia,
‡
Kim Kramer,* Melissa Fazzari,
†
Glenn Heller,
†
Lishi Chen,
§
and William L. Gerald
§
From the Departments of Pediatrics, * Biostatistics,
†
Pediatric
Surgery,
‡
and Pathology,
§
Memorial Sloan-Kettering Cancer
Center, New York, New York
Deletion of the short arm of chromosome 1 is fre-
quently observed in neuroblastoma (NB). We per-
formed loss of heterozygosity (LOH) analysis of 120
well characterized NB to better define specific regions
of 1p loss and any association with clinical and bio-
logical prognostic features (DNA index , MYCN ...
[865]
Neuroblastoma
[71,3 KB]
From [www.wch.sa.gov.au] Last viewed: 25.07.2004
Section 4 – Your Child’s Diagnosis – Neuroblastoma Page 1 of 3
Neuroblastoma
What is a Neuroblastoma ?
Neuroblastoma is a tumour that begins in nerve tissues in the
neck, chest, abdomen, or pelvis. About 50% of neuroblastomas
start in the tissues of the adrenal glands located just above the
kidneys.
Often this tumour has spread before it is diagnosed. The common
sites are the lymph nodes, liver, bones, and bone marrow.
Neuroblastoma occurs in early childhood with 2/3 of the children
younger than 5 years of age when they are diagnosed. Some
neuroblastomas in infants can spontaneously regress and your
doctor will discuss this with you.
What causes a neuroblastoma ?
As with most cancers, the cause of neuroblastoma is unknown.
What are the signs and symptoms?
The symptoms will vary depending on where the tumour is located.
The most common ...
[866]
Cadmium-Induced Apoptosis in MES 23.5 Mouse Neuroblastoma Cells
[51,5 KB]
From [www.utexas.edu] Last viewed: 25.07.2004
15
Cadmium-Induced Apoptosis in
MES 23.5 Mouse Neuroblastoma
Cells
Presenter
Wei-Wei Cheng
Collaborators
Li-xin Liu, Angela Gentles, Jean Strhlendrof, Louise Chiodo and Ernest
Smith, Texas Tech University
Department
Cell and Molecular Biology
Abstract
Exposure to the heavy metal, cadmium (Cd2+), has been linked to adverse environmental
and human health effects. The present studies addressed the mechanisms of Cd2+-induced
cell death in the mouse neuroblastoma X rat mesencephalon (MES-23.5) wild type cell line.
Toxicity initially was indexed using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenytetrazolium
bromide (MTT) assay following exposure to Cd2+ (1-10_M) for 7 to 72 h. Cell death was
observed to be both concentration- and time-dependent. The highest concentration resulted
in 100% cell death following 72 h exposure via the culture medium. We directly evaluated ...
[867]
In vitro Cytotoxicity Screening of Human Neuroblastoma Cells
[103,6 KB]
From [www.promega.com] Last viewed: 25.07.2004
C y t o t o x i c i t y S c r e e n i n g
N E U R A L N O T E S I S S U E 2 1 2 0 0 2
I
N VITRO
C
YTOTOXICITY
S
CREENING OF
H
UMAN
N
EUROBLASTOMA
C
ELLS
by Randy Hoffman, B.S., and Megan Buros,
Promega Corporation
Introduction
Robotic integration of cell-based assays for in vitro toxicity
screening of chemical compounds is becoming an
increasingly important aspect of the drug discovery
process. Development of assays that simplify the
automation process is crucial for the success of this high-
throughput screening. Promega has recently introduced
the CytoTox-ONE™ Homogeneous Membrane Integrity
Assay
(a)
, a fluorometric method for estimating the number
of non-viable cells present in multiwell plates. Combining
this assay with Promega’s Apo-ONE™ ...
[868]
040402 Neuroblastoma Screening at One Year of Age
[97,2 KB]
From [info.imsd.uni-mainz.de] Last viewed: 25.07.2004
N Engl J Med, Vol. 346, No. 14
·
April 4, 2002
·
www.nejm.org
·
1047
N E U R O B L ASTO M A S C R E E N I N G
NEUROBLASTOMA SCREENING AT ONE YEAR OF AGE
F
REIMUT
H. S
CHILLING
, M.D., C
LAUDIA
S
PIX
, P
H
.D., F
RANK
B
ERTHOLD
, M.D., R
UDOLF
E
RTTMANN
, M.D.,
N
ATALJA
F
EHSE
, M.D., B
ARBARA
H
ERO
, M.D., G
ISELA
K
LEIN
, P
H
.D., J
OHANNES
S
ANDER
, M.D., K
ERSTIN
S
CHWARZ
, M.D.,
J
OERN
T
REUNER
, M.D., U
LRICH
Z
ORN
, P
H
.D.,
AND ...
[869]
Neuroblastoma: A Disease Requiring a Multitude of Imaging Studies
[644,2 KB]
From [jnm.snmjournals.org] Last viewed: 25.07.2004
!"#$ P
O
! VP
S
NMU
ABSTRACT
A child with neuroblastoma was hospitalized due to fever on November 6, 2003. During the hospitalization (11/06/
2003-12/06/2003), the peripheral stem cells were collected from this child. The caring duration of the author was from
November 20, 2003 through November 26, 2003. This article describes the medical and nursing interventions imple-
mented for solving this child's health problems. As Gordon's 11 Functional Health Assessment served as an assessment
guide, four health problems, such as risk for infection, altered oral mucous membrane, hyperthermia, and pain, were
identified. In order to solve four health problems mentioned above, nursing goals were first identified and nursing inter-
ventions were then implemented. After evaluating the nursing care planed for this child, four health problems were either
improved or solved. This care experience may provide health ...
[870]
p16/p14 Cell Cycle Regulatory Pathways in Primary Neuroblastoma ...
[257,3 KB]
From [clincancerres.aacrjournals.org] Last viewed: 25.07.2004
1
The transcription factor EGR-1 promotes apoptosis of neuroblastoma cells.
Short title: Role of EGR-1 in neuroblastoma cell death.
Miguel Pignatelli
*‡
, Rosario Luna-Medina
*‡
, Arturo Pérez-Rendón
*
, Angel Santos
†
& Ana
Perez-Castillo
*
‡
Both authors contributed equally to this paper
*
.- Instituto de Investigaciones Biomédicas, Consejo Superior de Investigaciones Científicas-
Universidad Autónoma, 28029-Madrid.
†
.- Departamento de Bioquímica y Biología Molecular, Facultad de.Medicina, Universidad
Complutense, Madrid.
Requests for reprints:
- Ana Perez-Castillo. Instituto de Investigaciones Biomédicas, Consejo Superior de
Investigaciones Científicas-Universidad Autónoma, 28029-Madrid. Spain. Phone:
34-91-5854625, Fax: 34-91-5854587, E-mail: aperez@iib.uam.es . Or ...